Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Certara (CERT) stocks in Canada
Learn how to easily invest in Certara stocks.
Certara is a biotechnology business based in the US. Certara stocks (CERT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $25.86 – a decrease of 3.27% over the previous week. Certara employs 846 staff and has a trailing 12-month revenue of around $275.4 million.
How to buy shares in Certara
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CERT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Certara stock price (NASDAQ:CERT)Use our graph to track the performance of CERT stocks over time.
Certara shares at a glance
|Latest market close||$26.88|
|52-week range||$23.75 - $45.48|
|50-day moving average||$30.31|
|200-day moving average||$30.37|
|Wall St. target price||$40.60|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.40|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Certara stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Certara price performance over time
|1 week (2022-01-13)||-3.27%|
|1 month (2021-12-20)||-2.29%|
|3 months (2021-10-20)||-29.73%|
|6 months (2021-07-20)||7.91%|
|1 year (2021-01-20)||-26.56%|
|2 years (2020-01-16)||N/A|
|3 years (2019-01-16)||N/A|
|5 years (2017-01-16)||N/A|
Is Certara under- or over-valued?
Valuing Certara stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Certara's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Certara's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.5 million.
The EBITDA is a measure of a Certara's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$275.4 million|
|Gross profit TTM||$142.8 million|
|Return on assets TTM||-2.09%|
|Return on equity TTM||-7.9%|
|Market capitalisation||$4.4 billion|
TTM: trailing 12 months
Certara share dividends
We're not expecting Certara to pay a dividend over the next 12 months.
Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, and Australia.
Stocks similar to Certara
Certara in the news
Certara : Statement of Changes in Beneficial Ownership (Form 4)
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Riverbridge Partners Llc Buys Amedisys Inc, Privia Health Group Inc, Progyny Inc, Sells Gentex ...
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.